Asia: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Asia

In 2021, after three years of decline, there was significant growth in the Asian medicaments containing corticosteroid hormones market, when its value increased by 5.3% to $X. Over the period under review, consumption recorded a relatively flat trend pattern. Over the period under review, the market reached the maximum level at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Production of Medicaments Containing Corticosteroid Hormones in Asia

In value terms, medicaments containing corticosteroid hormones production soared to $X in 2021 estimated in export price. Overall, production recorded a deep contraction. The pace of growth was the most pronounced in 2015 with an increase of 31%. Over the period under review, production attained the peak level at $X in 2012; however, from 2013 to 2021, production failed to regain momentum.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in Asia

In 2021, overseas shipments of medicaments containing corticosteroid hormones increased by 37% to X tons, rising for the fifth year in a row after two years of decline. Overall, exports showed a buoyant expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones exports stood at $X in 2021. Over the period under review, exports, however, continue to indicate a noticeable descent. The pace of growth appeared the most rapid in 2014 with an increase of 64%. The level of export peaked at $X in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

India (X tons) and Pakistan (X tons) represented roughly 62% of total exports in 2021. China (X tons) held the next position in the ranking, distantly followed by Turkey (X tons). All these countries together held near 26% share of total exports. Indonesia (X tons) and Japan (X tons) held a little share of total exports.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Turkey (with a CAGR of +25.8%), while the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones supplying countries in Asia were Japan ($X), India ($X) and China ($X), together accounting for 65% of total exports. Pakistan, Turkey and Indonesia lagged somewhat behind, together comprising a further 12%.

Pakistan, with a CAGR of +16.0%, saw the highest growth rate of the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the export price in Asia amounted to $X per ton, with a decrease of -17.8% against the previous year. In general, the export price recorded a deep contraction. The most prominent rate of growth was recorded in 2014 when the export price increased by 40% against the previous year. Over the period under review, the export prices hit record highs at $X per ton in 2012; however, from 2013 to 2021, the export prices failed to regain momentum.

Prices varied noticeably country of origin: the country with the highest price was Japan ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+3.3%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in Asia

In 2021, supplies from abroad of medicaments containing corticosteroid hormones increased by 12% to X tons for the first time since 2018, thus ending a two-year declining trend. Total imports indicated a buoyant expansion from 2012 to 2021: its volume increased at an average annual rate of +6.8% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 with an increase of 19%. The volume of import peaked in 2021 and is expected to retain growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones imports amounted to $X in 2021. Total imports indicated a resilient expansion from 2012 to 2021: its value increased at an average annual rate of +6.5% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +78.5% against 2013 indices. The growth pace was the most rapid in 2018 with an increase of 14% against the previous year. Over the period under review, imports attained the maximum in 2021 and are likely to continue growth in the near future.

Imports by Country

In 2021, China (X tons), distantly followed by Japan (X tons), Afghanistan (X tons), Saudi Arabia (X tons), Turkey (X tons) and Iran (X tons) represented the largest importers of medicaments containing corticosteroid hormones, together creating 61% of total imports. Vietnam (X tons), Malaysia (X tons), the United Arab Emirates (X tons), Pakistan (X tons), South Korea (X tons), Thailand (X tons) and Singapore (X tons) held a minor share of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Afghanistan (with a CAGR of +58.8%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones importing markets in Asia were China ($X), Japan ($X) and South Korea ($X), together comprising 68% of total imports. These countries were followed by Turkey, the United Arab Emirates, Vietnam, Saudi Arabia, Thailand, Iran, Singapore, Malaysia, Afghanistan and Pakistan, which together accounted for a further 17%.

Afghanistan, with a CAGR of +45.5%, saw the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia stood at $X per ton in 2021, shrinking by -5.2% against the previous year. Over the period under review, the import price recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2017 an increase of 7%. Over the period under review, import prices reached the maximum at $X per ton in 2014; however, from 2015 to 2021, import prices failed to regain momentum.

Prices varied noticeably country of destination: the country with the highest price was South Korea ($X per ton), while Afghanistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Singapore (+10.7%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :